NewslettersCancer Stem Cell NewsMammary Cell News Downregulation of TAB182 Promotes Cancer Stem-Like Cell Properties and Therapeutic Resistance in Triple-Negative Breast Cancer Cells By Bob - November 15, 2023 0 The authors revealed a novel function of TAB182 as a potential negative regulator of cancer stem-like properties and drug sensitivity in triple-negative breast cancer cells. [BMC Cancer] Full Article